Dosidal · Switzerland

Nasobol Inhalo, Brausetabletten zur Herstellung eines Dampfs zur Inhalation

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:55737 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 55737
atc: R05X
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2003-06-03
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: R05X
authorisation_number: 55737
form: BRTDI
holder: Spirig HealthCare AG
holder_partner_nr: 1003095
it_number: 12.03.3.
name: Nasobol Inhalo, Brausetabletten zur Herstellung eines Dampfs zur Inhalation
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
e2fgY-Az5i-AGuSS9PHN8YaMQehAdr7HWcCaiP_lzeNhzYl05LPn9-iPFgYWKtmiGyZCvn8NEP0G61lQBnZVbA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal